(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(0.37%) $79.29
(1.04%) $1.952
(1.01%) $2 334.30
(1.07%) $27.04
(1.32%) $967.50
(0.03%) $0.933
(0.02%) $11.03
(-0.04%) $0.798
(0.06%) $93.51
Live Chart Being Loaded With Signals
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe...
Stats | |
---|---|
今日成交量 | 66 301.00 |
平均成交量 | 72 089.00 |
市值 | 324.48M |
EPS | £0 ( 2023-11-08 ) |
下一个收益日期 | ( £0 ) 2024-06-13 |
Last Dividend | £0.200 ( 2001-07-04 ) |
Next Dividend | £0 ( N/A ) |
P/E | -4.22 |
ATR14 | £4.31 (0.45%) |
音量 相关性
Biotech Growth Trust PLC 相关性
10 最正相关 | |
---|---|
AFRN.L | 0.952 |
LXI.L | 0.928 |
LOK.L | 0.925 |
VMUK.L | 0.919 |
ALFA.L | 0.917 |
JMI.L | 0.917 |
BNKS.L | 0.916 |
UTL.L | 0.916 |
SDIP.L | 0.914 |
NOG.L | 0.911 |
10 最负相关 | |
---|---|
GLB.L | -0.947 |
UD04.L | -0.925 |
AMC.L | -0.918 |
UAI.L | -0.917 |
7DIG.L | -0.916 |
INX.L | -0.912 |
FCCN.L | -0.907 |
BVIC.L | -0.905 |
UNG.L | -0.905 |
TFG.L | -0.903 |
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Biotech Growth Trust PLC 相关性 - 货币/商品
Biotech Growth Trust PLC 财务报表
Annual | 2022 |
营收: | £-37.65M |
毛利润: | £-37.65M (100.00 %) |
EPS: | £-1.030 |
FY | 2022 |
营收: | £-37.65M |
毛利润: | £-37.65M (100.00 %) |
EPS: | £-1.030 |
FY | 2022 |
营收: | £-209.71M |
毛利润: | £-209.71M (100.00 %) |
EPS: | £-4.88 |
FY | 2021 |
营收: | £222.06M |
毛利润: | £0.00 (0.00 %) |
EPS: | £4.44 |
Financial Reports:
No articles found.
Biotech Growth Trust PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
First Dividend | £0.600 | 1998-07-13 |
Last Dividend | £0.200 | 2001-07-04 |
Next Dividend | £0 | N/A |
Payout Date | 2001-07-30 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | £1.200 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.26 | -- |
Div. Sustainability Score | 2.02 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0.0839 | -- |
Year | Amount | Yield |
---|---|---|
1998 | £0.600 | 0.62% |
1999 | £0.400 | 0.57% |
2000 | £0 | 0.00% |
2001 | £0.200 | 0.10% |
2002 | £0 | 0.00% |
2003 | £0 | 0.00% |
2004 | £0 | 0.00% |
2005 | £0 | 0.00% |
2006 | £0 | 0.00% |
2007 | £0 | 0.00% |
2008 | £0 | 0.00% |
2009 | £0 | 0.00% |
2010 | £0 | 0.00% |
2011 | £0 | 0.00% |
2012 | £0 | 0.00% |
2013 | £0 | 0.00% |
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £0 | 0.00% |
2019 | £0 | 0.00% |
2020 | £0 | 0.00% |
2021 | £0 | 0.00% |
2022 | £0 | 0.00% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TRD.L | Dividend Junior | 2023-07-13 | Annually | 29 | 3.35% | |
MCON.L | Dividend Knight | 2023-11-16 | Semi-Annually | 11 | 0.48% | |
CRS.L | Dividend King | 2023-06-15 | Semi-Annually | 14 | 12.74% | |
SAA.L | No Dividend Player | 2023-06-08 | Annually | 20 | 0.27% | |
HSBA.L | Dividend Knight | 2023-08-10 | Semi-Annually | 32 | 3.65% | |
BBOX.L | Dividend King | 2023-08-10 | Quarterly | 11 | 2.62% | |
VTU.L | Dividend Knight | 2023-06-29 | Annually | 14 | 1.47% | |
MUL.L | Ex Dividend Junior | 2023-10-26 | Sporadic | 29 | 0.20% | |
DUKE.L | Dividend King | 2023-09-28 | Quarterly | 8 | 3.65% | |
SMJ.L | Dividend Knight | 2023-05-04 | Semi-Annually | 33 | 1.30% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 1.050 | 1.500 | 10.00 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.299 | 1.200 | -9.95 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.295 | 1.500 | -4.39 | -6.58 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.298 | 0.800 | -3.51 | -2.81 | [1 - 3] |
quickRatioTTM | 0.298 | 0.800 | -2.95 | -2.36 | [0.8 - 2.5] |
cashRatioTTM | 0.212 | 1.500 | 9.93 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0742 | -1.500 | 8.76 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -176.03 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.159 | 2.00 | -0.0530 | -0.106 | [0 - 30] |
freeCashFlowPerShareTTM | -0.159 | 2.00 | -0.0795 | -0.159 | [0 - 20] |
debtEquityRatioTTM | 0.0780 | -1.500 | 9.69 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 1.000 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 1.044 | 1.000 | 10.00 | 10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.260 | 1.000 | -2.56 | -2.56 | [0.2 - 2] |
assetTurnoverTTM | -0.284 | 0.800 | -5.23 | -4.18 | [0.5 - 2] |
Total Score | 2.02 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -3.88 | 1.000 | -0.493 | 0 | [1 - 100] |
returnOnEquityTTM | -0.295 | 2.50 | -2.82 | -6.58 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.159 | 2.00 | -0.0530 | -0.159 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.159 | 2.00 | -0.0530 | -0.106 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -4.92 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0679 | 1.000 | -0.803 | 0 | [0.1 - 0.5] |
Total Score | -1.856 |
Biotech Growth Trust PLC
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。